Successful treatment of psychosis in dentatorubral‐pallidoluysian atrophy with quetiapine: A case report
Abstract Introduction Patients with dentatorubral‐pallidoluysian atrophy (DRPLA) sometimes elicit psychosis. First‐generation antipsychotic drugs have been reported to be effective in treating psychotic symptoms associated with the disease. However, little information is available on the benefits of...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Wiley,
2018-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_b1ef5b3787374dae8a89fcc30bd788c8 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Zui Narita |e author |
| 700 | 1 | 0 | |a Tomiki Sumiyoshi |e author |
| 245 | 0 | 0 | |a Successful treatment of psychosis in dentatorubral‐pallidoluysian atrophy with quetiapine: A case report |
| 260 | |b Wiley, |c 2018-03-01T00:00:00Z. | ||
| 500 | |a 2574-173X | ||
| 500 | |a 10.1002/npr2.12005 | ||
| 520 | |a Abstract Introduction Patients with dentatorubral‐pallidoluysian atrophy (DRPLA) sometimes elicit psychosis. First‐generation antipsychotic drugs have been reported to be effective in treating psychotic symptoms associated with the disease. However, little information is available on the benefits of second‐generation antipsychotic drugs (SGAs). Case We report on a 47‐year‐old man with DRPLA whose psychotic symptoms were effectively treated with quetiapine, one of the SGAs. He suffered from delusions, auditory hallucinations, and disorganized speech. Initially, other antipsychotic drugs were tried, but were withdrawn because of adverse effects before switching to quetiapine. Conclusion Our observations add to the notion that some of the SGAs are useful for ameliorating psychosis in DRPLA. | ||
| 546 | |a EN | ||
| 690 | |a antipsychotics | ||
| 690 | |a progressive myoclonic epilepsies | ||
| 690 | |a psychosis | ||
| 690 | |a second generation | ||
| 690 | |a spinocerebellar degenerations | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 690 | |a Neurosciences. Biological psychiatry. Neuropsychiatry | ||
| 690 | |a RC321-571 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Neuropsychopharmacology Reports, Vol 38, Iss 1, Pp 44-46 (2018) | |
| 787 | 0 | |n https://doi.org/10.1002/npr2.12005 | |
| 787 | 0 | |n https://doaj.org/toc/2574-173X | |
| 856 | 4 | 1 | |u https://doaj.org/article/b1ef5b3787374dae8a89fcc30bd788c8 |z Connect to this object online. |